Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Heterogeneity of gene expression profiles in head and neck cancer.
Pramana J, Pimentel N, Hofland I, Wessels LF, van Velthuysen ML, Atsma D, Rasch CR, van den Brekel MW, Begg AC. Pramana J, et al. Among authors: pimentel n. Head Neck. 2007 Dec;29(12):1083-9. doi: 10.1002/hed.20621. Head Neck. 2007. PMID: 17615564
Gene expression profiling to predict outcome after chemoradiation in head and neck cancer.
Pramana J, Van den Brekel MW, van Velthuysen ML, Wessels LF, Nuyten DS, Hofland I, Atsma D, Pimentel N, Hoebers FJ, Rasch CR, Begg AC. Pramana J, et al. Among authors: pimentel n. Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1544-52. doi: 10.1016/j.ijrobp.2007.08.032. Epub 2007 Oct 10. Int J Radiat Oncol Biol Phys. 2007. PMID: 17931799 Clinical Trial.
Phenotype-Oriented Ablation of Oligometastatic Cancer with Single Dose Radiation Therapy.
Greco C, Pares O, Pimentel N, Louro V, Morales J, Nunes B, Castanheira J, Oliveira C, Silva A, Vaz S, Costa D, Zelefsky M, Kolesnick R, Fuks Z. Greco C, et al. Among authors: pimentel n. Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):593-603. doi: 10.1016/j.ijrobp.2019.02.033. Epub 2019 Feb 21. Int J Radiat Oncol Biol Phys. 2019. PMID: 30797891 Clinical Trial.
Safety and Efficacy of Virtual Prostatectomy With Single-Dose Radiotherapy in Patients With Intermediate-Risk Prostate Cancer: Results From the PROSINT Phase 2 Randomized Clinical Trial.
Greco C, Pares O, Pimentel N, Louro V, Santiago I, Vieira S, Stroom J, Mateus D, Soares A, Marques J, Freitas E, Coelho G, Seixas M, Lopez-Beltran A, Fuks Z. Greco C, et al. Among authors: pimentel n. JAMA Oncol. 2021 May 1;7(5):700-708. doi: 10.1001/jamaoncol.2021.0039. JAMA Oncol. 2021. PMID: 33704378 Free PMC article. Clinical Trial.
Positron Emission Tomography-Derived Metrics Predict the Probability of Local Relapse After Oligometastasis-Directed Ablative Radiation Therapy.
Greco C, Pares O, Pimentel N, Louro V, Morales J, Nunes B, Antunes I, Vasconcelos AL, Kociolek J, Castanheira J, Oliveira C, Silva A, Vaz S, Oliveira F, Carrasquinha E, Costa D, Fuks Z. Greco C, et al. Among authors: pimentel n. Adv Radiat Oncol. 2021 Dec 5;7(2):100864. doi: 10.1016/j.adro.2021.100864. eCollection 2022 Mar-Apr. Adv Radiat Oncol. 2021. PMID: 35036636 Free PMC article.
Spinal metastases: From conventional fractionated radiotherapy to single-dose SBRT.
Greco C, Pares O, Pimentel N, Moser E, Louro V, Morales X, Salas B, Fuks Z. Greco C, et al. Among authors: pimentel n. Rep Pract Oncol Radiother. 2015 Nov-Dec;20(6):454-63. doi: 10.1016/j.rpor.2015.03.004. Epub 2015 Apr 18. Rep Pract Oncol Radiother. 2015. PMID: 26696786 Free PMC article. Review.
Target motion mitigation promotes high-precision treatment planning and delivery of extreme hypofractionated prostate cancer radiotherapy: Results from a phase II study.
Greco C, Pares O, Pimentel N, Louro V, Morales J, Nunes B, Vasconcelos AL, Antunes I, Kociolek J, Stroom J, Viera S, Mateus D, Cardoso MJ, Soares A, Marques J, Freitas E, Coelho G, Fuks Z. Greco C, et al. Among authors: pimentel n. Radiother Oncol. 2020 May;146:21-28. doi: 10.1016/j.radonc.2020.01.029. Epub 2020 Feb 19. Radiother Oncol. 2020. PMID: 32087469 Clinical Trial.
44 results